Imperial Ginseng Products Ltd.
IGPFF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.09 | 0.11 | 0.02 | -0.00 |
| FCF Yield | -9.12% | -14.08% | -13.85% | -1.70% |
| EV / EBITDA | -11.69 | -14.37 | -4.62 | 0.87 |
| Quality | ||||
| ROIC | -25.86% | -15.50% | -23.98% | -10.05% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.30 | 2.78 | 1.43 | -0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 35.15% | -8.04% | -704.56% | -102.72% |
| Safety | ||||
| Net Debt / EBITDA | 2.57 | 5.35 | 3.60 | -1.15 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |